Clinical

Two posters summarized the safety of nivolumab in lung cancer and in glioblastoma, at the ASCO annual meeting.

A study published in the Journal of the American College of Surgeons evaluated whether the reducing resident duty hours improved surgical outcomes of patients.

A study of Kaiser Permanente cancer patients found that two-thirds of teen and young adult patients received aggressive care at the end of life. The special issue on the topic comes as CMS proposes paying doctors or nurses to discuss advanced care planning.

A new study published in Neurology, has shown that long-term inflammation in older patients with diabetes can also hasten their cognitive decline.

Till Kalydeco was approved, cystic fibrosis patients primarily received only disease management support to extend their lives.

In part 1 of "First Do No Harm," Ms Madden noted important new research suggesting that the majority of patients with HER2+ breast cancer who are treated with the anti-HER2 agent trastuzumab do not receive sufficient cardiac monitoring. In part 2, she discusses the implications of this recent study for patients with this aggressive form of breast cancer and protective strategies against preventable harms of their treatment.

The widespread use of screening mammography increases the probability of detecting smaller cancers without a decline in the detection of large cancers.

ICLIO promises to guide oncologists in community care practices to navigate the growing field of immuno-oncology.

Although the CDC expects death rates for most cancers to decrease by 2020, melanoma is the exception and new cases are expected to cost $1.6 billion in 2030.

To evaluate the current status of cancer mortality following the initiation of HP2020, CDC scientists evaluated population trends and made projections on cancer deaths based on race and gender.

With a growing understanding of the risk of cardiotoxicity associated with cancer treatment, cardio-oncology has emerged as an important subspecialty, resulting in the establishment of cardio-oncology programs most often based at or in collaboration with comprehensive cancer centers.

A study published in Health Affairs has found that primary care physicians refer women Medicaid enrollees to fewer preventive services than do their counterparts with private insurance coverage.

The Attorney General of Massachussetts, Maura Healy, wants healthcare services in the state to pay increased attention to mental health benefits.

Scientists at the Imperial College London have identified a genetic link to obesity and diabetes in an extremely obese woman and her family members.

The Swiss drug giant Novartis is looking at alternate pricing models for its heart failure drug Entresto, which is expected to gain FDA approval in August.

A week after JAMA released a report that found more than two-thirds of Americans age 25 years and older are overweight or obese, the American Academy of Pediatrics presented updated guidelines on preventing childhood obesity and recommendations for parents to help their children maintain a healthy weight.

Heterogeneity in Medicaid coverage of the anti-viral agent sofosbuvir is rampant across the United States, with varying reimbursement criteria and lack of conformation to recommendations by professional infectious disease organizations.

Researchers at the University of Michigan Medical School have developed a map of the United States highlighting significant variation in stroke care.

A pediatric long-term care facility in New York initiated an antibiotic-stewardship program to regulate the unnecessary prescribing of antibiotics.

Researchers at the MD Anderson Cancer Center have developed a blood test that can detect very early stages of pancreatic cancer before disease progression.

The JAMA authors recommend that HHS and the US Department of Agriculture pay attention to DGAC's recommendations on fat intake, which do not include an upper limit on total fat consumption.

NICE has updated and redesigned its guideline to support primary care physicians to recognize the signs and symptoms of 37 different cancers and refer people for the right tests faster.

A clinical trial at the University of Alabama will be enrolling patients in the first-ever study of an open-label placebo in cancer.

When evaluating the cost-effectiveness of 4 different interventions to prevent or reduce childhood obesity, researchers found that the benefit of these interventions surpassed the current clinical interventions to treat obesity.

Although drug development is expensive, the high prices being charged for some specialty drugs, like Sovaldi, are not required to induce innovation, Len M. Nichols, PhD, wrote Monday for Morning Consult.